Winkle RA, Mead RH, Engel G, Salcedo J, Brodt C, Barberini P, et al. Very long term outcomes of atrial fibrillation ablation. Heart Rhythm. 2023. https://doi.org/10.1016/j.hrthm.2023.02.002.
Makati KJ, Sood N, Lee LS, Yang F, Shults CC, DeLurgio DB, et al. Combined epicardial and endocardial ablation for atrial fibrillation: best practices and guide to hybrid convergent procedures. Heart Rhythm. 2021;18(2):303–12. https://doi.org/10.1016/j.hrthm.2020.10.004. Hybrid ablation procedures of atrial fibrillation – how to optimize patient selection and improve the procedural approach.
Eranki A, Wilson-Smith AR, Williams ML, et al. Hybrid convergent ablation versus endocardial catheter ablation for atrial fibrillation: a systematic review and meta-analysis of randomised control trials and propensity matched studies. J Cardiothorac Surg. 2022;17(181). https://doi.org/10.1186/s13019-022-01930-7.
DeLurgio DB, Crossen KJ, Gill J, Blauth C, Oza SR, Magnano AR, et al. Hybrid convergent procedure for the treatment of persistent and long-standing persistent atrial fibrillation: results of CONVERGE Clinical Trial. Circ Arrhythm Electrophysiol. 2020;13(12):e009288. https://doi.org/10.1161/CIRCEP.120.009288. Hybrid ablation procedures of atrial fibrillation – how to optimize patient selection and improve the procedural approach.
Article CAS PubMed Google Scholar
Shrestha S, Plasseraud KM, Makati K, Sood N, Killu AM, Contractor T, et al. Hybrid convergent ablation for atrial fibrillation: A systematic review and meta-analysis. Heart Rhythm O2. 2022;3(4):396–404. https://doi.org/10.1016/j.hroo.2022.05.006.
Article PubMed PubMed Central Google Scholar
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021;42(5):373–498. https://doi.org/10.1093/eurheartj/ehaa612. Hybrid ablation procedures of atrial fibrillation – how to optimize patient selection and improve the procedural approach.
Van Loo I, Asmundis CD, Meir ML. The 7 pillars of a successful hybrid atrial fibrillation program. Innov: Technol Tech Cardiothorac Vasc Surg. 2019;14(6):493–7. https://doi.org/10.1177/1556984519877264.
Ad N, Henry L, Hunt S, Stone L. The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation. J Thorac Cardiovasc Surg. 2010;139(5):1146–52. https://doi.org/10.1016/j.jtcvs.2010.01.034.
Haldar S, Khan HR, Boyalla V, Kralj-Hans I, Jones S, Lord J, et al. Catheter ablation vs. thoracoscopic surgical ablation in long-standing persistent atrial fibrillation: CASA-AF randomized controlled trial. Eur Heart J. 2020;41(47):4471–80. https://doi.org/10.1093/eurheartj/ehaa658.
Article PubMed PubMed Central Google Scholar
Kress DC. Characterizing recurrence following hybrid ablation in patients with persistent atrial fibrillation. J Patient-Centered Res Rev. 2020;7(3):227–38.
Delurgio DB, Blauth C, Halkos ME, Crossen KJ, Talton D, Oza SR, et al. Hybrid epicardial-endocardial ablation for long-standing persistent atrial fibrillation: a subanalysis of the CONVERGE trial. Heart Rhythm. 2022. https://doi.org/10.1016/j.hroo.2022.11.007.
Maclean E, Yap J, Saberwal B, Kolvekar S, Lim W, Wijesuriya N, et al. The convergent procedure versus catheter ablation alone in longstanding persistent atrial fibrillation: a single centre, propensity-matched cohort study. Int J Cardiol. 2020;303:49–53. https://doi.org/10.1016/j.ijcard.2019.10.053.
Article CAS PubMed Google Scholar
Makati KJ, Sherman AJ, Gerogiannis I, Sood N. Safety and efficacy of convergent hybrid procedure using cryo as endocardial energy source for the treatment of atrial fibrillation. Circ Arrhythm Electrophysiol. 2020;13(11):e008556. https://doi.org/10.1161/CIRCEP.120.008556.
Mittal S. Differentiating paroxysmal from persistent atrial fibrillation. J Am Coll Cardiol. 2014;63(25):2849–51. https://doi.org/10.1016/j.jacc.2014.04.020.
Charitos EI, Pürerfellner H, Glotzer TV, Ziegler PD. Clinical classifications of atrial fibrillation poorly reflect its temporal persistence: insights from 1,195 patients continuously monitored with implantable devices. J Am Coll Cardiol. 2014;63(25, Part A):2840–8. https://doi.org/10.1016/j.jacc.2014.04.019.
Potpara TS, Lip GYH, Blomstrom-Lundqvist C, Boriani G, Van Gelder IC, Heidbuchel H, et al. The 4S-AF scheme (stroke risk; symptoms; severity of burden; substrate): a novel approach to in-depth characterization (rather than classification) of atrial fibrillation. Thromb Haemost. 2021;121(03):270–8. https://doi.org/10.1055/s-0040-1716408.
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace. 2018;20(1):157–208. https://doi.org/10.1093/europace/eux275.
Kerendi F, Tschopp D, Maningat A, Hyde B, Coffeen P, Punske BB. Abstract 13439: long-term outcomes from continuous rhythm monitoring after hybrid convergent procedure in longstanding persistent atrial fibrillation patients. Circulation. 2021;144(Suppl_1):A13439-A. https://doi.org/10.1161/circ.144.suppl_1.13439.
Larson J, Merchant FM, Patel A, Ndubisi NM, Patel AM, DeLurgio DB, et al. Outcomes of convergent atrial fibrillation ablation with continuous rhythm monitoring. J Cardiovasc Electrophysiol. 2020;31(6):1270–6. https://doi.org/10.1111/jce.14454.
Wang TJ, Larson MG, Levy D, Vasan RS, Leip EP, Wolf PA, et al. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality. Circulation. 2003;107(23):2920–5. https://doi.org/10.1161/01.cir.0000072767.89944.6e.
Gopinathannair R, Chen LY, Chung MK, Cornwell WK, Furie KL, Lakkireddy DR, Marrouche NF, Natale A, Olshansky B, Joglar JA; on behalf of the American Heart Association Electrocardiography and Arrhythmias Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Hypertension; Council on Lifestyle and Cardiometabolic Health; and the Stroke Council. Managing atrial fibrillation in patients with heart failure and reduced ejection fraction: a scientific statement from the American Heart Association. Circ Arrhythm Electrophysiol. 2021;14:e000078.https://doi.org/10.1161/HAE.0000000000000078.
Marrouche NF, Brachmann J, Andresen D, Siebels J, Boersma L, Jordaens L, et al. Catheter ablation for atrial fibrillation with heart failure. N Engl J Med. 2018;378(5):417–27. https://doi.org/10.1056/nejmoa1707855.
Mannakkara NN, Porter B, Child N, Sidhu BS, Mehta VS, Elliott MK, et al. Convergent ablation for persistent atrial fibrillation: outcomes from a single-center real-world experience. Eur J Cardiothorac Surg. 2022. https://doi.org/10.1093/ejcts/ezac515.
Article PubMed PubMed Central Google Scholar
Gulkarov I, Wong B, Kowalski M, Worku B, Afzal A, Ivanov A, et al. Convergent ablation for persistent atrial fibrillation: single center experience. J Card Surg. 2019;34(10):1037–43. https://doi.org/10.1111/jocs.14204.
Derejko P, Polańska M, Chojnowska L, Michałowska I, Wójcik A, Piotrowicz E, et al. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate. Kardiol Pol. 2013;71(1):17–24.
Oza S, Crossen K, Magnano AR, Merchant FM, Joseph L, De Lurgio DB. Emerging evidence of improvement in left ventricular ejection fraction after convergent ablation in persistent and long-standing persistent AF patients with reduced ejection fraction. D-PO03-015 to DPO03-237. Heart Rhythm. 2020;17(5):S291-S382. https://cslide-us.ctimeetingtech.com/hrs20/attendee/eposter/poster/1155?q=Oza.
Kiankhooy A, Pierce C, Burk S, Phillips A, Eisenberg S, Dunnington G. Hybrid ablation of persistent and long-standing persistent atrial fibrillation with depressed ejection fraction: a single center observational study. JTCVS Open. 2022. https://doi.org/10.1016/j.xjon.2022.08.014.
Article PubMed PubMed Central Google Scholar
Zhuang J, Wang Y, Tang K, Li X, Peng W, Liang C, et al. Association between left atrial size and atrial fibrillation recurrence after single circumferential pulmonary vein isolation: a systematic review and meta-analysis of observational studies. Europace. 2012;14(5):638–45. https://doi.org/10.1093/europace/eur364.
Vaziri SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 1994;89(2):724–30. https://doi.org/10.1161/01.cir.89.2.724.
Article CAS PubMed Google Scholar
Patel DA, Lavie CJ, Milani RV, Shah S, Gilliland Y. Clinical implications of left atrial enlargement: a review. Ochsner J. 2009;9(4):191–6.
PubMed PubMed Central Google Scholar
Njoku A, Kannabhiran M, Arora R, Reddy P, Gopinathannair R, Lakkireddy D, et al. Left atrial volume predicts atrial fibrillation recurrence after radiofrequency ablation: a meta-analysis. Europace. 2018;20(1):33–42. https://doi.org/10.1093/europace/eux013.
Damiano RJ Jr, Schwartz FH, Bailey MS, Maniar HS, Munfakh NA, Moon MR, et al. The Cox maze IV procedure: predictors of late recurrence. J Thorac Cardiovasc Surg. 2011;141(1):113–21. https://doi.org/10.1016/j.jtcvs.2010.08.067.
Article PubMed PubMed Central Google Scholar
Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28(1):1-39.e14. https://doi.org/10.1016/j.echo.2014.10.003.
Wang Y, Gutman JM, Heilbron D, Wahr D, Schiller NB. Atrial volume in a normal adult population by two-dimensional echocardiography. Chest. 1984;86(4):595–601. https://doi.org/10.1378/chest.86.4.595.
Article CAS PubMed Google Scholar
Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61(2):755–9. https://doi.org/10.1016/0003-4975(95)00887-x.
Article CAS PubMed Google Scholar
Whitlock RP, Belley-Cote EP, Paparella D, Healey JS, Brady K, Sharma M, et al. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021;384(22):2081–91. https://doi.org/10.1056/nejmoa2101897.
Lakkireddy D, Thaler D, Ellis CR, Swarup V, Sondergaard L, Carroll J, et al. Amplatzer amulet left atrial appendage occluder versus watchman device for stroke prophylaxis (amulet IDE): a randomized, controlled trial. Circulation. 2021;144(19):1543–52. https://doi.org/10.1161/circulationaha.121.057063.
Article PubMed PubMed Central Google Scholar
Reddy VY, Doshi SK, Kar S, Gibson DN, Price MJ, Huber K, et al. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF Trials. J Am Coll Cardiol. 2017;70(24):2964–75. https://doi.org/10.1016/j.jacc.2017.10.021.
留言 (0)